Baseline patient characteristics across neutralizing monoclonal antibody trials. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Study Flow Diagram. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Overview of the six original ACTIV-3/TICO trials. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Means ratings for FFM traits at each age interval for the self and others with post hoc analyses for mean differences. حسب Joanna Gutral (12101779)

Distribution of mean seasonal rainfall in the study area. حسب Menbere Sahilu (18195856)

الموضوعات:

Distribution of mean monthly rainfall in the study area. حسب Menbere Sahilu (18195856)

الموضوعات:

Percentage decrease in model output peak with the administration of exogenous estrogen/progesterone. حسب Brenda Lyn A. Gavina (15285185)

Descriptive statistics of data presented in Tables 2–5. حسب Héctor Raúl Olivares-Sánchez (13014866)

RNF5 loss decreases PEL xenograft tumor growth and cell cycle gene expression. حسب Xiaojuan Li (351842)

Chemokines, with the exception of CXCL1 and MCP-1, decrease acutely following 5 Gy IR. حسب Jordan A. Gunning (18143970)

Fig 5 - حسب Harshita Sharma (4836180)

Descriptive statistics (mean [standard deviation] or % [sample size]) for study variables analyzed in the current study. حسب Angelina R. Sutin (9216456)

Mean change in pain severity and interference from baseline to 8 weeks. حسب Judith I. Tsui (5983160)

الموضوعات:

Effects of FE and RUD wrist postures on the mean carpal tunnel depth within each quartile. حسب Drew A. Anderson (14197446)

الموضوعات: